Zomedica Corp.
ZOMDF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001684144
No open-market purchases or sales by Zomedica Corp. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $9.50K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Zomedica Corp. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +1 vs. Q3 2021
- Shares held
- 125.4M
- +5.14M (+4.3%) vs. Q3 2021
- Total value
- $38.5M
- −$24.5M (−38.9%) vs. Q3 2021
- New holders
- 20
- 32 more added
- Sold out
- 19
- 26 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZOMDF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 7 | $9.50K |
| Q1 2026 | 8 | $122.7K |
| Q4 2025 | 7 | $126.1K |
| Q3 2025 | 9 | $140.5K |
| Q2 2025 | 10 | $209.2K |
| Q1 2025 | 23 | $386.6K |
| Q4 2024 | 92 | $11.0M |
| Q3 2024 | 85 | $11.1M |
| Q2 2024 | 97 | $12.4M |
| Q1 2024 | 98 | $12.3M |
| Q4 2023 | 93 | $17.7M |
| Q3 2023 | 88 | $14.1M |
| Q2 2023 | 93 | $19.5M |
| Q1 2023 | 91 | $20.5M |
| Q4 2022 | 92 | $15.3M |
| Q3 2022 | 88 | $19.5M |
| Q2 2022 | 98 | $20.8M |
| Q1 2022 | 112 | $38.3M |
| Q4 2021 | 108 | $38.5M |
| Q3 2021 | 107 | $63.0M |
| Q2 2021 | 106 | $108.9M |
| Q1 2021 | 102 | $160.3M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Zomedica Corp.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Swiss National Bank | 2,045,100 | $627.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 2,244,336 | $687.0K | 0.00% | +15,929+0.7% | Added |
| Brown Brothers Harriman & Co | 2,285,532 | $701.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 7,753,949 | $2.38M | 0.00% | −393,399−4.8% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 11,142,660 | $3.42M | 0.02% | +8450.0% | Added |
| BlackRock Inc. | 12,710,306 | $3.90M | 0.00% | −5,403,693−29.8% | Reduced |
| State Street Corp | 28,730,202 | $8.81M | 0.00% | +5,932,371+26.0% | Added |
| Vanguard Group Inc | 41,635,682 | $12.8M | 0.00% | +181,358+0.4% | Added |
| HRT Financial LP | 0 | $0 | 0.00% | −399,494−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −399,217−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −226,649−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −171,126−100.0% | Sold out |
| SkyView Investment Advisors, LLC | 0 | $0 | 0.00% | −41,650−100.0% | Sold out |
| National Asset Management, Inc. | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −10,829−100.0% | Sold out |
| RiverGlades Family Offices LLC | 0 | $0 | 0.00% | −10,900−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| LVW Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Foundations Investment Advisors, LLC | 0 | $0 | 0.00% | −10,226−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −7,044−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| TSFG, LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| FourThought Financial, LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Ironwood Financial, llc | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| Gerber Kawasaki Wealth & Investment Management | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Joseph P. Lucia & Associates, LLC | 0 | $0 | 0.00% | −750−100.0% | Sold out |